203 related articles for article (PubMed ID: 30026606)
1. Telomere length and survival in primary cutaneous melanoma patients.
Rachakonda S; Srinivas N; Mahmoudpour SH; Garcia-Casado Z; Requena C; Traves V; Soriano V; Cardelli M; Pjanova D; Molven A; Gruis N; Nagore E; Kumar R
Sci Rep; 2018 Jul; 8(1):10947. PubMed ID: 30026606
[TBL] [Abstract][Full Text] [Related]
2. Telomere length, telomerase reverse transcriptase promoter mutations, and melanoma risk.
Rachakonda S; Kong H; Srinivas N; Garcia-Casado Z; Requena C; Fallah M; Heidenreich B; Planelles D; Traves V; Schadendorf D; Nagore E; Kumar R
Genes Chromosomes Cancer; 2018 Nov; 57(11):564-572. PubMed ID: 30203894
[TBL] [Abstract][Full Text] [Related]
3. Telomere length and the risk of cutaneous melanoma and non-melanoma skin cancer: a review of the literature and meta-analysis.
Caini S; Raimondi S; Johansson H; De Giorgi V; Zanna I; Palli D; Gandini S
J Dermatol Sci; 2015 Dec; 80(3):168-74. PubMed ID: 26341697
[TBL] [Abstract][Full Text] [Related]
4. Differences in telomere length between sporadic and familial cutaneous melanoma.
Menin C; Bojnik E; Del Bianco P; Elefanti L; Gianesin K; Keppel S; Stagni C; Mocellin S; Vecchiato A; De Rossi A
Br J Dermatol; 2016 Nov; 175(5):937-943. PubMed ID: 27061190
[TBL] [Abstract][Full Text] [Related]
5. The telomere profile distinguishes two classes of genetically distinct cutaneous squamous cell carcinomas.
Leufke C; Leykauf J; Krunic D; Jauch A; Holtgreve-Grez H; Böhm-Steuer B; Bröcker EB; Mauch C; Utikal J; Hartschuh W; Purdie KJ; Boukamp P
Oncogene; 2014 Jul; 33(27):3506-18. PubMed ID: 23955078
[TBL] [Abstract][Full Text] [Related]
6. Telomere length and risk of melanoma, squamous cell carcinoma, and basal cell carcinoma.
Anic GM; Sondak VK; Messina JL; Fenske NA; Zager JS; Cherpelis BS; Lee JH; Fulp WJ; Epling-Burnette PK; Park JY; Rollison DE
Cancer Epidemiol; 2013 Aug; 37(4):434-9. PubMed ID: 23523330
[TBL] [Abstract][Full Text] [Related]
7. Independent replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohort.
Nsengimana J; Laye J; Filia A; Walker C; Jewell R; Van den Oord JJ; Wolter P; Patel P; Sucker A; Schadendorf D; Jönsson GB; Bishop DT; Newton-Bishop J
Oncotarget; 2015 May; 6(13):11683-93. PubMed ID: 25871393
[TBL] [Abstract][Full Text] [Related]
8. Shorter telomeres associate with a reduced risk of melanoma development.
Nan H; Du M; De Vivo I; Manson JE; Liu S; McTiernan A; Curb JD; Lessin LS; Bonner MR; Guo Q; Qureshi AA; Hunter DJ; Han J
Cancer Res; 2011 Nov; 71(21):6758-63. PubMed ID: 22028319
[TBL] [Abstract][Full Text] [Related]
9. Skin phenotypes can offer some insight about the association between telomere length and cancer susceptibility.
Ribero S; Mangino M; Bataille V
Med Hypotheses; 2016 Dec; 97():7-10. PubMed ID: 27876133
[TBL] [Abstract][Full Text] [Related]
10. Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients.
Lee JH; Saw RP; Thompson JF; Lo S; Spillane AJ; Shannon KF; Stretch JR; Howle J; Menzies AM; Carlino MS; Kefford RF; Long GV; Scolyer RA; Rizos H
Ann Oncol; 2019 May; 30(5):815-822. PubMed ID: 30860590
[TBL] [Abstract][Full Text] [Related]
11. Long telomere length and a TERT-CLPTM1 locus polymorphism association with melanoma risk.
Llorca-Cardeñosa MJ; Peña-Chilet M; Mayor M; Gomez-Fernandez C; Casado B; Martin-Gonzalez M; Carretero G; Lluch A; Martinez-Cadenas C; Ibarrola-Villava M; Ribas G
Eur J Cancer; 2014 Dec; 50(18):3168-77. PubMed ID: 25457634
[TBL] [Abstract][Full Text] [Related]
12. Genetic predisposition to long telomeres is associated with increased mortality after melanoma: A study of 2101 melanoma patients from hospital clinics and the general population.
Ismail H; Helby J; Hölmich LR; H Chakera A; Bastholt L; Klyver H; Sjøgren P; Schmidt H; Schöllhammer L; Nordestgaard BG; Bojesen SE
Pigment Cell Melanoma Res; 2021 Sep; 34(5):946-954. PubMed ID: 33749133
[TBL] [Abstract][Full Text] [Related]
13. Leukocyte telomere length associates with nasopharyngeal carcinoma risk and survival in Hong Kong Chinese.
Ko JM; Tsang KH; Dai W; Choi SSA; Leong MM; Ngan RK; Kwong DL; Cheng A; Lee AW; Ng WT; Tung S; Lee VH; Lam KO; Chan CK; Lung ML
Int J Cancer; 2018 Nov; 143(9):2289-2298. PubMed ID: 29873071
[TBL] [Abstract][Full Text] [Related]
14. On the interplay of telomeres, nevi and the risk of melanoma.
Bodelon C; Pfeiffer RM; Bollati V; Debbache J; Calista D; Ghiorzo P; Fargnoli MC; Bianchi-Scarra G; Peris K; Hoxha M; Hutchinson A; Burdette L; Burke L; Fang S; Tucker MA; Goldstein AM; Lee JE; Wei Q; Savage SA; Yang XR; Amos C; Landi MT
PLoS One; 2012; 7(12):e52466. PubMed ID: 23300679
[TBL] [Abstract][Full Text] [Related]
15. Highly Aggressive Metastatic Melanoma Cells Unable to Maintain Telomere Length.
Viceconte N; Dheur MS; Majerova E; Pierreux CE; Baurain JF; van Baren N; Decottignies A
Cell Rep; 2017 Jun; 19(12):2529-2543. PubMed ID: 28636941
[TBL] [Abstract][Full Text] [Related]
16. Clinical validation of a prognostic 11-gene expression profiling score in prospectively collected FFPE tissue of patients with AJCC v8 stage II cutaneous melanoma.
Amaral TMS; Hoffmann MC; Sinnberg T; Niessner H; Sülberg H; Eigentler TK; Garbe C
Eur J Cancer; 2020 Jan; 125():38-45. PubMed ID: 31838403
[TBL] [Abstract][Full Text] [Related]
17. Association of the POT1 Germline Missense Variant p.I78T With Familial Melanoma.
Wong K; Robles-Espinoza CD; Rodriguez D; Rudat SS; Puig S; Potrony M; Wong CC; Hewinson J; Aguilera P; Puig-Butille JA; Bressac-de Paillerets B; Zattara H; van der Weyden L; Fletcher CDM; Brenn T; Arends MJ; Quesada V; Newton-Bishop JA; Lopez-Otin C; Bishop DT; Harms PW; Johnson TM; Durham AB; Lombard DB; Adams DJ
JAMA Dermatol; 2019 May; 155(5):604-609. PubMed ID: 30586141
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of telomere length and the risk of skin cancer.
Han J; Qureshi AA; Prescott J; Guo Q; Ye L; Hunter DJ; De Vivo I
J Invest Dermatol; 2009 Feb; 129(2):415-21. PubMed ID: 18668136
[TBL] [Abstract][Full Text] [Related]
19. Observational and genetic studies of short telomeres and Alzheimer's disease in 67,000 and 152,000 individuals: a Mendelian randomization study.
Scheller Madrid A; Rasmussen KL; Rode L; Frikke-Schmidt R; Nordestgaard BG; Bojesen SE
Eur J Epidemiol; 2020 Feb; 35(2):147-156. PubMed ID: 31564046
[TBL] [Abstract][Full Text] [Related]
20. Long telomeres and cancer risk among 95 568 individuals from the general population.
Rode L; Nordestgaard BG; Bojesen SE
Int J Epidemiol; 2016 Oct; 45(5):1634-1643. PubMed ID: 27498151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
